Related content

Central European Society for Anticancer Drug Research (CESAR)

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 492-493

Karger

Access to resources Recommend Favorite

SOP 07a: Monitoring of a Trial under CESAR Responsibility

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-11 ,pp. : 38-40

Karger

Access to resources Recommend Favorite

SOP 02: Evaluation and Selection of a Clinical Trial Proposal for CESAR

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-11 ,pp. : 5-10

Karger

Access to resources Recommend Favorite

Reply to ESMO guidelines committee comment on ‘Critical evaluation of the scientific content in clinical practice guidelines’

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1908-1909

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 5-13

Karger

Access to resources Recommend Favorite